| Line item | 2025-11-30 FY | 2024-11-30 FY | 2023-11-30 FY | 2022-11-30 FY | 2021-11-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | $6.92M | $8.62M |
| R&D | – | – | – | – | – |
| SG&A | $1.33M | $1.22M | $1.33M | $1.29M | $1.52M |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$42.24M | -$8.59M | -$14.95M | -$24.26M | -$21.66M |
| EPS (basic) | -0.2600 | -0.0500 | -0.1000 | -0.1700 | -0.1500 |
| EPS (diluted) | -0.2600 | -0.0500 | -0.1000 | -0.1700 | -0.1500 |
| Shares (diluted) | $164.82M | $159.83M | $152.65M | $145.72M | $144.43M |